Upgrade to SI Premium - Free Trial

Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Oppenheimer

May 19, 2021 5:07 AM
Oppenheimer analyst Mark Breidenbach lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles